John T. Liles

890 total citations
25 papers, 560 citations indexed

About

John T. Liles is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, John T. Liles has authored 25 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in John T. Liles's work include Nitric Oxide and Endothelin Effects (7 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Renin-Angiotensin System Studies (5 papers). John T. Liles is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Renin-Angiotensin System Studies (5 papers). John T. Liles collaborates with scholars based in United States, Australia and Austria. John T. Liles's co-authors include David G. Breckenridge, Y. Frank, David J. Nikolic‐Paterson, Yingjie Han, Greg H. Tesch, Philip J. Kadowitz, Grant R. Budas, Paul Dabisch, Hartmut Jaeschke and Yuchao Xie and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Diabetes and The FASEB Journal.

In The Last Decade

John T. Liles

25 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John T. Liles United States 14 206 108 99 89 85 25 560
Priska Kaufmann Switzerland 13 307 1.5× 151 1.4× 56 0.6× 151 1.7× 127 1.5× 36 777
Jean‐Marie Brusq France 7 301 1.5× 55 0.5× 94 0.9× 30 0.3× 124 1.5× 8 629
Agnieszka Kij Poland 16 237 1.2× 81 0.8× 133 1.3× 34 0.4× 60 0.7× 40 670
Russell Esterline United States 15 214 1.0× 66 0.6× 73 0.7× 39 0.4× 153 1.8× 26 589
Robert N. Schuck United States 17 162 0.8× 110 1.0× 115 1.2× 37 0.4× 64 0.8× 43 855
Vajir Malek India 18 277 1.3× 230 2.1× 78 0.8× 45 0.5× 84 1.0× 28 764
Xiao-Yong Yu China 14 313 1.5× 50 0.5× 90 0.9× 92 1.0× 75 0.9× 21 788
Ewa Waszkiewicz Poland 14 130 0.6× 171 1.6× 60 0.6× 50 0.6× 88 1.0× 30 509
Xuping Yang China 14 285 1.4× 45 0.4× 150 1.5× 28 0.3× 138 1.6× 36 667
Zsuzsanna Ament United States 14 322 1.6× 48 0.4× 146 1.5× 36 0.4× 41 0.5× 27 622

Countries citing papers authored by John T. Liles

Since Specialization
Citations

This map shows the geographic impact of John T. Liles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Liles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Liles more than expected).

Fields of papers citing papers by John T. Liles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Liles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Liles. The network helps show where John T. Liles may publish in the future.

Co-authorship network of co-authors of John T. Liles

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Liles. A scholar is included among the top collaborators of John T. Liles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Liles. John T. Liles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hollenback, David, Eva Hambruch, Andreas Schulz, et al.. (2024). Development of Cilofexor, an Intestinally-Biased Farnesoid X Receptor Agonist, for the Treatment of Fatty Liver Disease. Journal of Pharmacology and Experimental Therapeutics. 389(1). 61–75. 3 indexed citations
2.
Fuchs, Claudia, Hubert Scharnagl, Ruchi Gupta, et al.. (2023). Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2-/- mouse model of sclerosing cholangitis. JHEP Reports. 5(11). 100874–100874. 15 indexed citations
3.
Abedini, Amin, Mustafa Al‐Obaidi, Kishor Devalaraja‐Narashimha, et al.. (2022). An Interim Analysis of Clinical and Histopathological Results of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study. Journal of the American Society of Nephrology. 33(11S). 119–119. 1 indexed citations
4.
Schwabl, Philipp, Eva Hambruch, Grant R. Budas, et al.. (2021). The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model. Biomedicines. 9(1). 60–60. 49 indexed citations
5.
Wilson, K., Kornelija Suveizdytė, John T. Liles, et al.. (2020). Apoptosis signal‐regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension. Pulmonary Circulation. 10(2). 1–16. 5 indexed citations
6.
Ozols, Elyce, John Kanellis, Shawn S. Badal, et al.. (2020). Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis. International Journal of Molecular Sciences. 22(1). 271–271. 16 indexed citations
7.
Budas, Grant R., Mario Boehm, Baktybek Kojonazarov, et al.. (2017). ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 197(3). 373–385. 77 indexed citations
8.
Xie, Yuchao, Anup Ramachandran, David G. Breckenridge, et al.. (2015). Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury. Toxicology and Applied Pharmacology. 286(1). 1–9. 81 indexed citations
9.
Liles, John T., et al.. (2015). Ranolazine Reduces Remodeling of the Right Ventricle and Provoked Arrhythmias in Rats with Pulmonary Hypertension. Journal of Pharmacology and Experimental Therapeutics. 353(3). 480–489. 29 indexed citations
10.
Tesch, Greg H., Y. Frank, Yingjie Han, et al.. (2015). ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice. Diabetes. 64(11). 3903–3913. 80 indexed citations
11.
Boehm, Mario, Baktybek Kojonazarov, Hossein Ardeschir Ghofrani, et al.. (2015). Effects of apoptosis signal- regulating kinase 1 (ASK1) inhibition in experimental pressure overload-induced right ventricular dysfunction. PA4913–PA4913. 1 indexed citations
12.
Breckenridge, David G., John T. Liles, Grant R. Budas, et al.. (2012). An Apoptosis Signal-regulating Kinase 1 Inhibitor Reduces Cardiomyocyte Apoptosis and Infarct Size in a Rat Ischemia-reperfusion Model. Journal of Cardiovascular Pharmacology. 60(3). 276–282. 30 indexed citations
13.
Breckenridge, David G., John T. Liles, John C. Shryock, et al.. (2012). An apoptosis signal‐regulating kinase 1 inhibitor reduces cardiomyocyte apoptosis and infarct size in a rat ischemia‐reperfusion model. The FASEB Journal. 26(S1). 3 indexed citations
14.
Dabisch, Paul, et al.. (2007). Analysis ofl-NAME-dependent and -resistant responses to acetylcholine in the rat. American Journal of Physiology-Heart and Circulatory Physiology. 294(2). H688–H698. 13 indexed citations
15.
Liles, John T., Syed R. Baber, Weiwen Deng, et al.. (2006). Pressor responses to ephedrine are not impaired in dopamine β‐hydroxylase knockout mice. British Journal of Pharmacology. 150(1). 29–36. 14 indexed citations
16.
Liles, John T., Paul Dabisch, Leena Pradhan, et al.. (2005). Pressor Responses to Ephedrine Are Mediated by a Direct Mechanism in the Rat. Journal of Pharmacology and Experimental Therapeutics. 316(1). 95–105. 29 indexed citations
17.
Pradhan, Leena, Paul Dabisch, John T. Liles, et al.. (2005). Effect of binge cocaine treatment on hindlimb vascular function. Journal of Applied Toxicology. 25(6). 479–490. 9 indexed citations
18.
Dabisch, Paul, et al.. (2003). Role of potassium channels in the nitric oxide-independent vasodilator response to acetylcholine. Pharmacological Research. 49(3). 207–215. 13 indexed citations
19.
Dabisch, Paul, John T. Liles, & Philip J. Kadowitz. (2003). Effect of inhibition of nitric oxide synthase on the vasopressor response to ephedrine. Canadian Journal of Physiology and Pharmacology. 81(10). 966–971. 7 indexed citations
20.
Pradhan, Leena, Paul Dabisch, John T. Liles, Krishna C. Agrawal, & Philip J. Kadowitz. (2003). Effect of Acute Intravenous Cocaine Administration on Endothelium-Dependent Vasodepressor Responses to Acetylcholine. Journal of Cardiovascular Pharmacology and Therapeutics. 8(1). 43–51. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026